💊FDA PHARMA today

💊FDA PHARMA today

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Yervoy (ipilimumab) for the Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma | BMS Newsroom

http://www.ono.co.jp/jpnw/PDF/n17_1218.pdf

https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-receives-positive-chmp-opinion-recommendi